QATCH Technologies Email Format
Biotechnology ResearchNorth Carolina, United States2-10 Employees
QATCH Technologies is a biotechnology research startup based in North Carolina that focuses on life-science instrumentation. The company originated to commercialize a sensor technology developed at Duke University and is developing a tool to prescreen the injectability and manufacturability of biopharmaceutical drugs at early stages of development, leveraging the very small sample volumes involved. By enabling risk assessment in the preclinical phase, QATCH aims to help prevent delays in bringing important medicines to patients. The target market comprises biopharmaceutical developers seeking early-stage evaluation of drug candidates' formulation and manufacturing feasibility, addressing the need to de-risk clinical progression. In the broader biopharma instrumentation landscape, QATCH positions itself as a provider of early-stage screening capabilities that can inform manufacturing and development decisions before costly late-stage trials. The company operates with a focus on practical application of its sensor technology to improve efficiency and reliability in the preclinical development process.